Next Article in Journal
Design of a Hybrid Two-Degree-of-Freedom Lower Limb Exerciser
Previous Article in Journal
Dynamic Multi-Stage Gastrointestinal Digestion Model Assessment of Microbial Fermentation Products of Collagen Hydrolysates
 
 
Font Type:
Arial Georgia Verdana
Font Size:
Aa Aa Aa
Line Spacing:
Column Width:
Background:
Proceeding Paper

Biopotential of Sea Cucumbers (Echinodermata) and Tunicates (Chordata) from the Western Coast of Portugal for the Prevention and Treatment of Chronic Illnesses †

1
Faculty of Biomedical Sciences and Medicine FCBM, University of Algarve, Campus de Gambelas, 8005-139 Faro, Portugal
2
Centre of Marine Sciences, University of Algarve, Campus de Gambelas, 8005-139 Faro, Portugal
3
Division of Aquaculture, Upgrading and Bioprospection, Portuguese Institute for the Sea and Atmosphere, IPMA, Avenida Alfredo Magalhães Ramalho, 6, 1495-165 Algés, Portugal
4
Interdisciplinary Centre of Marine and Environmental Research (CIIMAR/CIMAR), University of Porto, Rua dos Bragas 289, 4050-123 Porto, Portugal
5
Division of Environmental Oceanography, Portuguese Institute for the Sea and Atmosphere, IPMA, Avenida Alfredo Magalhães Ramalho, 6, 1495-165 Algés, Portugal
6
Marine and Environmental Sciences Centre (MARE), NOVA University of Lisbon, 2829-516 Caparica, Portugal
7
MARE—Marine and Environmental Sciences Centre, Faculty of Science, University of Lisbon, Campo Grande, 1749-016 Lisbon, Portugal
8
Algarve Biomedical Center ABC, University of Algarve, Campus de Gambelas, 8005-139 Faro, Portugal
9
Centre for Biomedical Sciences CBMR, University of Algarve, Campus de Gambelas, 8005-139 Faro, Portugal
*
Author to whom correspondence should be addressed.
Presented at the 1st International Electronic Conference on Nutrients—Nutritional and Microbiota Effects on Chronic Disease, 2–15 November 2020; Available online: https://iecn2020.sciforum.net/.
These authors contributed equally to this work.
Proceedings 2020, 61(1), 13; https://doi.org/10.3390/IECN2020-06994
Published: 30 October 2020

Abstract

:
In the present work, we aimed to explore the potential of two groups of marine invertebrates—sea cucumbers (Echinodermata) and ascidians (Chordata)—as sources of anti-inflammatory, anti-oxidant, and osteogenic compounds with potential to be used as pharmaceuticals and nutraceuticals for the treatment and prevention of chronic diseases. 24 extracts (ethanol, water, and ethyl acetate) from 4 species of sea cucumbers and 4 species of tunicates were produced and screened in vitro for their anti-inflammatory and anti-oxidant activities and in vivo for osteogenic activity through an assay using zebrafish larvae. Our results showed that ethanolic extracts presented anti-oxidant and anti-inflammatory activity, which revealed to be stronger in the ascidians. The osteogenic activity, which provides evidence of the bioactive potential of these organisms in preventing chronic disorders causing low bone density, was found to be strong in one species of ascidians and 3 of holothurians. This study demonstrates the high potential of extracts from these marine organisms for using as nutraceuticals in the prevention of chronic bone disorders.

1. Introduction

Chronic diseases are a major cause of death and morbidity globally [1]. Among these, osteoporosis and osteopenia are the most common chronic disorders related to bone [2]. Although much remains unclear about the molecular mechanism underlying the development of chronic diseases, a growing body of evidence has stressed the importance of inflammation and oxidative stress. In this context, nutraceuticals and functional foods promise to be important sources of micronutrients, antioxidants, and anti-inflammatory compounds for the prevention of chronic diseases [3]. The marine environment is considered to be a potentially inexhaustible source of bioactive compounds. Sea cucumbers (Holothuroidea) and ascidians (Ascidiacea) have gained the attention of the pharmaceutical sector due to the large amount of bioactives isolated from these groups of marine invertebrates, that have been associated with anti-inflammatory, anti-oxidant, and osteogenic activities, among others [4,5]. In the present work, we evaluated the bioactivity of extracts produced from 4 species of sea cucumbers belonging to the family Holothuriidae and 4 species of ascidians, belonging to the families Styelidae and Polyclinidae. Our aim was to explore the bioactive potential of these species for applications in the prevention and treatment of bone related chronic disorders. Anti-inflammatory activity, anti-oxidant potential, and polyphenol content were assessed for the aqueous and ethanolic extracts obtained from sea cucumbers and ascidians. Furthermore, to evaluate the potential of these species, all the extracts were screened for their pro-osteogenic bioactivity within a recently developed zebrafish-based in vivo system.

2. Materials and Methods

Ethanol, water and ethyl acetate extracts were produced from 4 species of sea cucumbers belonging to the family Holothuriidae (Holothuriidae ni1, Holothuriidae ni2, Holothuriidae ni3, Holothuriidae ni4) and 4 species of ascidians, 1 from the family Styelidae (Styelidae ni1) and 3 from the family Polyclinidae (Polyclinidae ni1, Polyclinidae ni2, and Polyclinidae ni3), collected from the western coast of Portugal.

2.1. Preparation of the Extracts

A total of 24 extracts were obtained by solvent extraction from sea cucumbers and ascidians freeze-dried biomass. The biomass was ground into fine powder and solubilized in water, ethanol or ethyl acetate with a ratio 1:30 w/v. Solutions were homogenized and left for 16 h to extract soluble compounds. Extracts were centrifuged to remove insoluble material and aliquoted.

2.2. Anti-oxidant Activity and Polyphenol Content

Anti-oxidant potential was assessed for the ethanolic and aqueous extracts. Free radical scavenging capacity was assessed through the ferric reducing antioxidant power (FRAP), 2,2′-azinobis(3-ethylbenzothiazoline-6-sulfonic acid) (ABTS+) and 2,2-diphenyl-1-picryl-hydrazyl-hydrate (DPPH) methods [6,7]. The polyphenol content was determined in the aqueous and ethanolic extracts by colorimetric determination with phosphomolybdic-phosphotungstic acid, using a protocol adapted from Singleton et al. (1965) [8].

2.3. Anti-Inflammatory Activity

Anti-inflammatory activity was evaluated in the ethanolic and aqueous extracts by the cyclooxygenase-2 (COX-2) inhibitory assay, an established biomarker of inflammation processes [9].

2.4. Developmental Toxicity and Osteogenic Activity in Zebrafish Larvae

Aqueous, ethanolic and ethyl acetate extracts from sea cucumbers and ascidians were screened for their acute developmental toxicity in a 72-h exposure of zebrafish larvae. At 3 days post fertilization larvae were transferred to 6 well-plates with a density of 15 larvae per 10 mL of treatment medium/well. The larvae were treated via waterborne exposure for 72 h with different concentrations of each extract and the respective solvents as control groups (0.1% v/v ethanol for ethanol extracts, fish water for aqueous extracts; and 0.1% v/v Dimethyl sulfoxide (DMSO) for ethyl acetate extracts). Treatment medium was renewed daily (70%). All the extracts were first tested at a concentration of 100 µg/mL and toxicity was monitored during 3 days of exposure. Mortality and severe deformation were considered to be endpoints for toxicity. When the treatments were toxic, the dose was reduced to 10 or 31.6 µg/mL and the experimental exposure repeated. If no toxicity was observed, the dose increased to 200 µg/mL. The maximum non-lethal dose (MNLD) was selected to evaluate the osteogenic activity with the zebrafish operculum assay, an in vivo, phenotypic-based method that uses morphometric analysis of the opercular bone in alizarin red S-stained zebrafish larvae [10]. The area of the operculum (OpA) and the area of the head (HA) were measured and used to determine osteogenic activity.

3. Results and Discussion

3.1. Anti-Inflammatory Activity

The anti-inflammatory activity in the biomass of the eight species of marine organisms was measured as the percentage of inhibition of COX-2 (Table 1). The ethanolic extracts showed higher anti-inflammatory activity than the aqueous extracts, and the higher activity was reported for the ascidians.

3.2. Anti-oxidant Activity and Polyphenol Content

The anti-oxidant activity and polyphenol content are presented in Table 2. The set of three tunicate species belonging to the family Polyclinidae displayed the highest anti-oxidant activities in both extracts, with the only remarkable exceptions of the aqueous extracts of Polyclinidae ni1 and Polyclinidae ni2 with their anti-oxidant power measured by DPPH. The anti-oxidant activities determined for the holothurians were generally lower than the observed for the ascidians from the family Polyclinidae. The ethanolic extracts from the ascidians were richer in polyphenols than the aqueous extracts, while in holothurians the opposite was observed. Moreover, Polyclinidae had higher polyphenol contents compared with holothurians. Total polyphenol contents had a weak correlation with the anti-oxidant activity, even in the best case, i.e., DPPH (R2 = 0.29). It should be noted that there are other anti-oxidant substances in tunicates [11] and sea cucumbers [12] which may be responsible for the effect reported. Comparisons with the relevant literature must consider used methodologies, measurement units, and type of extract. Further research on the seasonality and overall variation of phenolic substances and anti-oxidant activity in tunicates and holothurians is required.

3.3. Developmental Toxicity and Osteogenic Activity

Acute developmental toxicity was calculated for the ethanolic, aqueous and ethyl acetate extracts from 4 species of sea cucumbers (Holothuriidae ni1, Holothuriidae ni2, Holothuriidae ni3, Holothuriidae ni4) and 4 species of ascidians (Styelidae ni1, Polyclinidae ni1, Polyclinidae ni2, and Polyclinidae ni3). Most of the aqueous and ethanolic extracts showed no toxicity at the concentrations tested, except for the ethanol extracts of Holothuriidae ni1 that induced mortality at the higher concentration (200 µg/mL). Oppositely, all the ethyl acetate extracts induced severe mortality at the higher concentration tested (100 µg/mL), indicating the possible presence of toxic compounds in the extracts. The MNLD determined for each extract was then used to assess the osteogenic activity. Control groups did not show mortality in any of the assays performed. The area of the operculum (OpA) and the area of the head (HA) were measured, and the ratio OpA/HA was calculated for assessing osteogenic activity (Figure 1). None of the extracts significantly affected the area of the head (HA), a proxy of the size of the larva, indicating there was no significant variation on growth among treatments.The ethanol extracts from Styelidae ni1 and Polyclinidae ni1 and ni3 induced moderate to high osteogenic activity by increasing the area of the operculum, when compared with the control. The ethanol extract from Polyclinidae ni1 showed the highest osteogenic activity by inducing an increase in the size of the opercular bone of 41 ± 16.66%. The ethyl acetate extracts induced moderate pro-osteogenic effects in Holothuriidae ni2 and ni4, but Polyclinidae ni1 induced the highest osteogenic effect, with an increase of the operculum area of 28.0 ± 13.84%. Regarding sea cucumbers, treatment with the ethanol extracts from Holothuriidae ni2, Holothuriidae ni3, and Holothuriidae ni4 showed a moderate osteogenic effect. This suggests the presence of osteogenic compounds in the extracts, with higher osteogenic power in the ethanolic extracts of the ascidians Styelidae ni1, Polyclinidae ni1, and ni3 and of the Holothurians Holothuriidae ni2, ni3 and ni4.
Despite many bioactive compounds being isolated from sea cucumbers and ascidians, the number of studies analyzing their potential for bone health is low and only based on in vitro studies.
Fucoidans derived from the holothurian Stichopus japonicus inhibited the differentiation of rat bone marrow macrophages into osteoclasts [13], similarly to what was observed for fucoidan extracted from brown seaweeds [14]. Furthermore, water and methanolic extracts from different species of sea cucumbers were found to be able to induce differentiation in human osteoblastic cell lines [15] and rat bone marrow mesenchymal stem cells [16]. Very few studies analyzed the osteo-active properties of compounds derived from ascidians. Calcitonin-like peptides isolated from the sea squirt Ciona intestinalis showed to be able to promote osteoblastic differentiation and mineralization in MC3T3-E1 cells [17]. Aplidin, a compound isolated from the ascidian Aplidium albicans, known for its anticancer potential, was able to reduce osteoclast differentiation when administered both alone or together with dexamethasone in both murine bone marrow primary cell culture and in an ex vivo bone organ culture model [18].
Interestingly, in the present study a significant correlation was found between the osteogenic activity and the COX-2-inhibitory activity for the extracts studied (R2 = 0.49). However, to understand the mechanisms underlying the biological activities observed, further investigation is needed to identify the compounds responsible for the effect observed by treatment with the extracts, but also to understand the molecular pathways underlying the observed osteogenic effects.

4. Conclusions

In the present work, we explored the potential of two promising groups of marine invertebrates as sources of bioactive compounds to be used toward the prevention and treatment of low-bone-density chronic diseases. The ethanolic extracts from ascidians showed the higher anti-oxidant and anti-inflammatory activities, while ethanolic extracts from two ascidians and two sea cucumbers showed high in vivo osteogenic activity by promoting bone formation in zebrafish larvae. These findings indicate that ethanolic extracts from both ascidians and sea cucumber are potential sources of compounds with health benefits, and require further research for chemical characterization of the extracts and identification of the compounds responsible for the effect reported.

Author Contributions

Conceptualization, A.C., C.C., L.C., N.B., P.J.G.; formal analysis, A.C., C.C., L.C., N.B., P.J.G.; investigation, A.C., C.C., L.C., N.B., P.J.G.; resources, C.C., L.C., N.B., P.J.G., M.J.G., P.C., M.A.D.; data curation, A.C., C.C., D.J., J.L.A., P.C., M.A.D., S.S., I.F., C.A.; writing—original draft preparation, A.C., C.C., P.J.G.; writing—review and editing, A.C., C.C., N.B., P.J.G., J.L.A., P.C., S.S.; supervision, C.C., N.B., M.J.G., L.C., P.J.G.; project administration, C.C., N.B., L.C., P.J.G., P.C., M.A.D.; funding acquisition, N.B., L.C., P.J.G., P.C. All authors have read and agreed to the published version of the manuscript.

Funding

This project received funding from the European Union’s Horizon 2020 research and innovation program under the Marie Skłodowska-Curie grant agreement No. 766347; from the project ProtectInvad (MAR-02.02.01-FEAMP-0004) funded by program MAR 2020; and from the Portuguese national funds from FCT—Foundation for Science and Technology through projects UIDB/04326/2020 and UIDB/04292/2020.

Conflicts of Interest

The authors declare no conflict of interest.

References

  1. Damasceno, A. Noncommunicable Diseases Country Profiles 2018; World Health Organization: Geneva, Switzerland, 2018. [Google Scholar]
  2. Reginster, J.-Y.; Burlet, N. Osteoporosis: A still increasing prevalence. Bone 2006, 38 (Suppl. 1), 4–9. [Google Scholar] [CrossRef] [PubMed]
  3. Bergamin, A.; Mantzioris, E.; Cross, G.; Deo, P.; Garg, S.; Hill, A.M. Nutraceuticals: Reviewing their Role in Chronic Disease Prevention and Management. Pharm. Med. 2019, 33, 291–309. [Google Scholar] [CrossRef] [PubMed]
  4. Khotimchenko, Y. Pharmacological Potential of Sea Cucumbers. Int. J. Mol. Sci. 2018, 19, 1342. [Google Scholar] [CrossRef] [PubMed]
  5. Blunt, J.W.; Copp, B.R.; Keyzers, R.A.; Munro, M.H.G.; Prinsep, M.R. Marine natural products. Nat. Prod. Rep. 2017, 34, 235–294. [Google Scholar] [CrossRef] [PubMed]
  6. Rodríguez-Bonilla, P.; Gandía-Herrero, F.; Matencio, A.; García-Carmona, F.; López-Nicolás, J.M. Comparative Study of the Antioxidant Capacity of Four Stilbenes Using ORAC, ABTS+, and FRAP Techniques. Food Anal. Methods 2017, 10, 2994–3000. [Google Scholar] [CrossRef]
  7. Kedare, S.B.; Singh, R.P. Genesis and development of DPPH method of antioxidant assay. J. Food Sci. Technol. 2011, 48, 412–422. [Google Scholar] [CrossRef] [PubMed]
  8. Singleton, V.L.; Rossi, J.A., Jr. Colorimetry of Total Phenolics with Phosphomolybdic-Phosphotungstic Acid Reagents. Am. J. Enol. Vitic. 1965, 16, 144–158. [Google Scholar]
  9. White, H.L.; Glassman, A.T. A simple radiochemical assay for prostaglandin synthetase. Prostaglandins 1974, 7, 123–129. [Google Scholar] [CrossRef]
  10. Tarasco, M.; Laizé, V.; Cardeira, J.; Cancela, M.L.; Gavaia, P.J. The zebrafish operculum: A powerful system to assess osteogenic bioactivities of molecules with pharmacological and toxicological relevance. Comp. Biochem. Physiol. Part C Toxicol. Pharmacol. 2017, 197, 45–52. [Google Scholar] [CrossRef] [PubMed]
  11. Zhang, X.; Liu, L.; Sun, M.; Chen, B.; Jiang, A. Preparation, chemical characterization and antioxidant activity of crude polysaccharide and oligosaccharide extracted from the ascidian Styela clava. J. Biotech Res. 2018, 9, 39–47. [Google Scholar]
  12. Nobsathian, S.; Tuchinda, P.; Sobhon, P.; Tinikul, Y.; Poljaroen, J.; Tinikul, R.; Sroyraya, M.; Poomton, T.; Chaichotranunt, S. An antioxidant activity of the whole body of Holothuria scabra. Chem. Biol. Technol. Agric. 2017, 4, 17–21. [Google Scholar] [CrossRef]
  13. Kariya, Y.; Mulloy, B.; Imai, K.; Tominaga, A.; Kaneko, T.; Asari, A.; Suzuki, K.; Masuda, H.; Kyogashima, M.; Ishii, T. Isolation and partial characterization of fucan sulfates from the body wall of sea cucumber Stichopus japonicus and their ability to inhibit osteoclastogenesis. Carbohydr. Res. 2004, 339, 1339–1346. [Google Scholar] [CrossRef] [PubMed]
  14. Kim, Y.W.; Baek, S.-H.; Lee, S.-H.; Kim, T.-H.; Kim, S.-Y. Fucoidan, a Sulfated Polysaccharide, Inhibits Osteoclast Differentiation and Function by Modulating RANKL Signaling. Int. J. Mol. Sci. 2014, 15, 18840–18855. [Google Scholar] [CrossRef] [PubMed]
  15. Shahrulazua, A.; Samsudin, A.; Iskandar, M.; Amran, A. The In-Vitro Effects of Sea Cucumber (Stichopus sp1) Extract on Human Osteoblast Cell Line. Malays. Orthop. J. 2013, 7, 41–48. [Google Scholar] [CrossRef] [PubMed]
  16. Baharara, J.; Amini, E.; Kerachian, M.A.; Soltani, M. The osteogenic differentiation stimulating activity of Sea cucumber methanolic crude extraction on rat bone marrow mesenchymal stem cells. Iran. J. Basic Med. Sci. 2014, 17, 626–631. [Google Scholar] [PubMed]
  17. Nguyen, V.-T.; Ko, S.-C.; Heo, S.-J.; Kang, D.H.; Oh, C.; Kim, K.-N.; Jeon, Y.-J.; Kim, Y.-M.; Park, W.S.; Choi, I.-W.; et al. Ciona intestinalis calcitonin-like peptide promotes osteoblast differentiation and mineralization through MAPK pathway in MC3T3-E1 cells. Process Biochem. 2018, 67, 127–138. [Google Scholar] [CrossRef]
  18. Delgado-Calle, J.; Kurihara, N.; Atkinson, E.G.; Nelson, J.; Miyagawa, K.; Galmarini, C.M.; Roodman, G.D.; Bellido, T. Aplidin (plitidepsin) is a novel anti-myeloma agent with potent anti-resorptive activity mediated by direct effects on osteoclasts. Oncotarget 2019, 10, 2709–2721. [Google Scholar] [CrossRef] [PubMed]
Figure 1. Osteogenic activity of water, ethanol, and ethyl acetate extracts from sea cucumbers and ascidians in zebrafish larvae. Both HA and OpA/HA are reported as percentage on the average of the control group (water, ethanol 0.1% v/v or DMSO 0.1% v/v respectively). The averages HA and OpA/HA of the control group for each extract tested is represented by the axis y =100 (%). Statistical differences among the means are tested through One-way ANOVA (between control and each condition). p values are indicated as follow: <0.0332 (*), <0.0021 (**), <0.0002 (***), <0.0001 (****).
Figure 1. Osteogenic activity of water, ethanol, and ethyl acetate extracts from sea cucumbers and ascidians in zebrafish larvae. Both HA and OpA/HA are reported as percentage on the average of the control group (water, ethanol 0.1% v/v or DMSO 0.1% v/v respectively). The averages HA and OpA/HA of the control group for each extract tested is represented by the axis y =100 (%). Statistical differences among the means are tested through One-way ANOVA (between control and each condition). p values are indicated as follow: <0.0332 (*), <0.0021 (**), <0.0002 (***), <0.0001 (****).
Proceedings 61 00013 g001
Table 1. Anti-inflammatory activity (% inhibition of COX-2) in aqueous and ethanolic extracts from 4 ascidian and four sea cucumber species. Values are presented as average ± SD. Different lowercase letters within a column correspond to statistical differences (p < 0.05) between organism species. Different uppercase letters within a row correspond to statistical differences (p < 0.05) between aqueous and ethanolic extracts. nd—not detected.
Table 1. Anti-inflammatory activity (% inhibition of COX-2) in aqueous and ethanolic extracts from 4 ascidian and four sea cucumber species. Values are presented as average ± SD. Different lowercase letters within a column correspond to statistical differences (p < 0.05) between organism species. Different uppercase letters within a row correspond to statistical differences (p < 0.05) between aqueous and ethanolic extracts. nd—not detected.
SpeciesAnti-Inflammatory Activity
Aqueous ExtractEthanolic Extract
Styelidae ni119.6 ± 5.8 c,A76.7 ± 3.4 c,B
Polyclinidae ni127.8 ± 2.5 d,A70.2 ± 6.3 c,B
Polyclinidae ni28.9 ± 3.7 b,A75.9 ± 3.0 c,B
Polyclinidae ni333.2 ± 5.2 d,A92.2 ± 8.5 d,B
Holothuriidae ni3nd a,A40.0 ± 7.6 b,B
Holothuriidae ni4nd a,A41.8 ± 4.9 b,B
Holothuriidae ni2nd a,A48.8 ± 3.4 b,B
Holothuriidae ni1nd a,A16.4 ± 9.7 a,B
Table 2. Anti-oxidant activity was measured by ABTS+ (μmol eq TROLOX/100 g dw), FRAP (µmol eq FeSO4/g dw), and DPPH (mg eq AA/100 g dw) and polyphenol content (mg GAE/100 g dw) in aqueous and ethanolic extracts. Values presented as average ± SD. For anti-oxidant activity, different lowercase letters within a column correspond to statistical differences (p < 0.05) between organism species. For each anti-oxidant method, different uppercase letters within a row correspond to statistical differences (p < 0.05) between aqueous and ethanolic extracts. Within the polyphenol’s column, different uppercase letters correspond to statistical differences (p < 0.05) between aqueous and ethanolic extracts. nd—not detected.
Table 2. Anti-oxidant activity was measured by ABTS+ (μmol eq TROLOX/100 g dw), FRAP (µmol eq FeSO4/g dw), and DPPH (mg eq AA/100 g dw) and polyphenol content (mg GAE/100 g dw) in aqueous and ethanolic extracts. Values presented as average ± SD. For anti-oxidant activity, different lowercase letters within a column correspond to statistical differences (p < 0.05) between organism species. For each anti-oxidant method, different uppercase letters within a row correspond to statistical differences (p < 0.05) between aqueous and ethanolic extracts. Within the polyphenol’s column, different uppercase letters correspond to statistical differences (p < 0.05) between aqueous and ethanolic extracts. nd—not detected.
SpeciesABTS+FRAPDPPHPolyphenols
ExtractExtractExtractExtract
AqueousEthanolicAqueousEthanolicAqueousEthanolicAqueousEthanolic
Styelidae ni11126 ± 81 a,A552 ± 60 b,B2.9 ± 0.5 a,A5.5 ± 0.1 b,B6.9 ± 10.9 a,b,Anda,B31 ± 6 a,A40 ± 7 b,A
Polyclinidae ni16206 ± 180 f,A5020 ± 20 d,B34.3 ± 0.4 e,A34.2 ± 0.1 d,And a,A102.0 ± 1.6 b,B260 ± 13 d,A365 ± 21 d,B
Polyclinidae ni26735 ± 11 g,A5886 ± 83 e,B54.6 ± 0.4 f,A56.5 ± 0.0 e,B16.7 ± 4.1 b,c,A179.0 ± 1.7 c,B428 ± 10 e,A669 ± 11 e,B
Polyclinidae ni34271 ± 109 e,A3027 ± 56 c,B19.7 ± 0.6 d,A15.6 ± 0.6 c,B151.7 ± 4.4 e,A162.7 ± 2.5 c,B103 ± 8 c,A206 ± 14 c,B
Holothuriidae ni32234 ± 136 c,A166 ± 35 a,B7.0 ± 0.2 b,A2.0 ± 0.1 a,Bnd a,A13.5 ± 12.7 a,B84 ± 4 b,c,A9 ± 5 a,b,B
Holothuriidae ni43089 ± 158 d,A33 ± 57 a,B6.2 ± 0.0 b,A1.5 ± 0.2 a,B31.8 ± 6.2 c,A5.7 ± 9.8 a,B79 ± 1 b,A21 ± 17 a,b,B
Holothuriidae ni22259 ± 45 c,A312 ± 320 a,b,B8.5 ± 0.2 c,A4.4 ± 1.5 b,B3.0 ± 5.1 a,b,A8.6 ± 8.5 a,A69 ± 2 b,A34 ± 11 a,b,B
Holothuriidae ni11883 ± 81 b,And a,B8.9 ± 0.5 c,A2.1 ± 0.6 a,B106.1 ± 4.7 d,And a,B48 ± 2 a,And a,B
Publisher’s Note: MDPI stays neutral with regard to jurisdictional claims in published maps and institutional affiliations.

Share and Cite

MDPI and ACS Style

Carletti, A.; Cardoso, C.; Juliao, D.; Arteaga, J.L.; Chainho, P.; Dionísio, M.A.; Sales, S.; Gaudêncio, M.J.; Ferreira, I.; Afonso, C.; et al. Biopotential of Sea Cucumbers (Echinodermata) and Tunicates (Chordata) from the Western Coast of Portugal for the Prevention and Treatment of Chronic Illnesses. Proceedings 2020, 61, 13. https://doi.org/10.3390/IECN2020-06994

AMA Style

Carletti A, Cardoso C, Juliao D, Arteaga JL, Chainho P, Dionísio MA, Sales S, Gaudêncio MJ, Ferreira I, Afonso C, et al. Biopotential of Sea Cucumbers (Echinodermata) and Tunicates (Chordata) from the Western Coast of Portugal for the Prevention and Treatment of Chronic Illnesses. Proceedings. 2020; 61(1):13. https://doi.org/10.3390/IECN2020-06994

Chicago/Turabian Style

Carletti, Alessio, Carlos Cardoso, Diana Juliao, Jorge L. Arteaga, Paula Chainho, Maria Ana Dionísio, Sabrina Sales, Maria J. Gaudêncio, Inês Ferreira, Cláudia Afonso, and et al. 2020. "Biopotential of Sea Cucumbers (Echinodermata) and Tunicates (Chordata) from the Western Coast of Portugal for the Prevention and Treatment of Chronic Illnesses" Proceedings 61, no. 1: 13. https://doi.org/10.3390/IECN2020-06994

APA Style

Carletti, A., Cardoso, C., Juliao, D., Arteaga, J. L., Chainho, P., Dionísio, M. A., Sales, S., Gaudêncio, M. J., Ferreira, I., Afonso, C., Lourenço, H., Cancela, M. L., Bandarra, N. M., & Gavaia, P. J. (2020). Biopotential of Sea Cucumbers (Echinodermata) and Tunicates (Chordata) from the Western Coast of Portugal for the Prevention and Treatment of Chronic Illnesses. Proceedings, 61(1), 13. https://doi.org/10.3390/IECN2020-06994

Article Metrics

Back to TopTop